Sofie Peirs

Cancer Clinic — United States

Medicine · Health Sciences

14h-index1.0kcitations47works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(28), Ubiquitin and proteasome pathways(10), CAR-T cell therapy research(9), Chronic Myeloid Leukemia Treatments(8), Acute Myeloid Leukemia Research(6)

Publications47 total

Editor’s Note: A Novel <scp>L</scp>-Asparaginase with low <scp>L</scp>-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias <i>In Vivo</i>
Cancer Research·2025Open Access
Figures S1-17 plus legends from USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia
2023Open Access
Supplementary Table 2 from USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia
2023Open Access
Supplementary Data from A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
Supplementary Data from A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
Data from A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
Figures S1-17 plus legends from USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia
2023Open Access
Supplementary Table 1 from USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia
2023Open Access
Supplementary Table 1 from USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia
2023Open Access
Data from A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
Data from USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia
2023Open Access
Data from USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia
2023Open Access
Supplementary Table 2 from USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia
2023Open Access
The spleen as a sanctuary site for residual leukemic cells following ABT-199 monotherapy in ETP-ALL
Blood Advances·2021· 20 citedOpen Access
RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia
Journal of Clinical Investigation·2021· 45 citedOpen Access
Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemia
PLoS ONE·2019· 20 citedOpen Access
PF157 THERAPEUTIC TARGETING OF CYTOKINE INDUCED PIM1 ACTIVATION IN T‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOMA
HemaSphere·2019Open Access
S860 TARGETING ABERRANT DNA METHYLATION AS A NOVEL AND UNIFORM THERAPEUTIC STRATEGY FOR THE TREATMENT OF T‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOMA
HemaSphere·2019Open Access
PRC2 Inactivation Induces Resistance to Chemotherapy-Induced Apoptosis By Upregulating the TRAP1 Mitochondrial Chaperone in T-ALL
Blood·2018
PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia
The Journal of Experimental Medicine·2018· 59 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Pieter Van Vlierberghe(46), Geert Berx(24), Steven Goossens(22), Niels Vandamme(21), Filip Matthijssens(18), Tim Lammens(16), Barbara De Moerloose(15), Tim Pieters(15), Jean‐Pierre Bourquin(13), Giuseppe Basso(13), Bruce Poppe(12), Beat Bornhäuser(12), Béatrice Lintermans(12), Valentina Serafin(11), Benedetta Accordi(11), Kelly M. Arcipowski(10), Yixing Zhu(10), Kenneth K. Wang(10), Megan R. Johnson(10), Andrew Volk(10)